[Federal Register Volume 71, Number 137 (Tuesday, July 18, 2006)]
[Notices]
[Pages 40721-40722]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-11340]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-06-06BL]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 
and send comments to Seleda Perryman, CDC Assistant Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail 
to [email protected].
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Evaluation of the HIV Testing Social Marketing Campaign (HTSMC)--
New--National Center for HIV/AIDS, Viral Hepatitis, STD, and TB 
Prevention (NCHHSTP), Coordinating Center for Infectious Diseases 
(CCID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    This project involves the evaluation of the HIV Testing Social 
Marketing Campaign (HTSMC), a CDC-sponsored social marketing campaign 
aimed at increasing HIV testing rates among young, single, African 
American women. The CDC has designed an efficacy study to evaluate the 
HTSMC and its messages under controlled conditions. The study entails 
selecting a sample of single African American females, ages 18 to 34, 
with less than 4 years of college education and collecting baseline 
data on their knowledge, attitudes, beliefs, intentions, and behaviors 
related to HIV testing. The study represents an ``efficacy'' 
methodology in that participants will be divided into treatment and 
control conditions. Participants in the treatment condition, will be 
exposed to campaign materials including radio advertisements, a 
billboard, and an informational booklet that will be distributed over 
the Internet. Thus the study participants' exposure will occur under 
controlled conditions, without the distractions and variability of 
potential exposure in the real world. As part of the advertisement 
stimuli package, the billboard advertisement will appear as part of the 
online log-in for each stimuli session in order to simulate the 
appearance of a sign. Therefore, we do not estimate any additional 
burden for exposure to the billboard advertisement.
    Key outcomes related to the HTSMC will be measured in two follow-up 
surveys. The first follow-up survey will occur 2 weeks after the 
baseline survey. The second follow-up survey will occur 6 weeks after 
the baseline survey. Comparisons of changes in these outcomes would 
then be made between participants in the treatment and control 
conditions. Findings from this study will be used by CDC and its 
partners to inform current and future program activities.
    We expect a total of 1,630 participants to complete the baseline 
survey. The 1,630 participants who complete the baseline survey will be 
randomly assigned to the treatment or control condition. 815 
participants (the treatment condition) will be exposed to the radio ad 
and booklet. Of the 1,630 participants who completed the baseline 
survey, we expect 1,140 to complete the first follow-up survey. Of the 
1,140 who complete the first follow-up survey, we expect 800 to 
complete the second follow-up survey, which will have fewer questions 
than the first follow-up survey because it will only pertain to 
questions about behavior change and selected behavioral intentions.
    There are no costs to the respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                          Responses                                     Total
                Respondents                  Number of       per      Average  burden per  response     burden
                                            respondents   respondent            (in hours)              hours
----------------------------------------------------------------------------------------------------------------
Baseline survey...........................        1,630            1  15/60                                  408
Radio ad stimuli viewing..................          815            1  18/60                                  245
Booklet reading...........................          815            1  15/60                                  204
Follow-up survey 1........................        1,140            1  15/60                                  285
Follow-up survey 2........................          800            1  5/60                                    67
                                           ---------------------------------------------------------------------
    Total.................................  ...........  ...........  .............................        1,209
----------------------------------------------------------------------------------------------------------------



[[Page 40722]]

    Dated: July 10, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
 [FR Doc. E6-11340 Filed 7-17-06; 8:45 am]
BILLING CODE 4163-18-P